Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
Karolina Rzeniewicz, Rohini Sharma · 2024
Read Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease by Karolina Rzeniewicz, Rohini Sharma (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11514420.txt.
Description
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death globally, with 15% of cases arising on a background of non-alcoholic fatty liver disease (NAFLD). NAFLD is a heterogenous condition ranging from fatty liver to cirrhosis and is itself a growing global problem, with estimated worldwide prevalence of 50% in 2040.
Catalog record
| CREATOR | Karolina Rzeniewicz, Rohini Sharma |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |